-
A SYSTEMATIC REVIEW OF FINDINGS AND METHODS IN ECONOMIC EVALUATIONS OF DYADIC HEALTHCARE INTERVENTIONS
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF PROCALCITONIN-GUIDED ANTIBIOTIC THERAPY IN ADULT PATIENTS WITH ACUTE RESPIRATORY INFECTION IN A COLOMBIAN REFERRAL HOSPITAL
Mar 18, 2026, 21:38 PM -
MODELLING HEALTH SYSTEM CAPACITY AND MEASUREMENT DISPERSION TO EXPLAIN CROSS-NATIONAL VARIATION IN EQVT UTILITY VALUES
Mar 18, 2026, 21:38 PM -
THE COST-EFFECTIVENESS OF CONTINUOUS GLUCOSE MONITORING (CGM) FOR ADULTS WITH TYPE 1 DIABETES IN IRELAND
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF SEMAGLUTIDE 2.4 MG COMPARED WITH RESMETIROM AND STANDARD OF CARE FOR METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS (MASH) IN THE U.S. USING MOST FAVORED NATION (MFN) PRICING
Mar 18, 2026, 21:38 PM -
BREAST CANCER PATTERNS AND TREATMENT ACCESS IN DENMARK: IDENTIFYING OPPORTUNITIES FOR DECENTRALIZED CARE IN BREAST CANCER CARE (HEATMAP-ONKO-BREAST)
Mar 18, 2026, 21:38 PM -
REAL-WORLD DIAGNOSTIC DELAY, TREATMENT ACCESS, AND HEALTH SYSTEM BURDEN IN PRIMARY IMMUNODEFICIENCY/INBORN ERRORS OF IMMUNITY: EVIDENCE FROM THE UNITED STATES AND EX-US SETTINGS
Mar 18, 2026, 21:38 PM -
WHEN IS REAL-WORLD EVIDENCE SCIENTIFICALLY SOUND? EXPERT CONSENSUS ON SASS FOR CFL COMMUNICATION
Mar 18, 2026, 21:38 PM -
BURNOUT AMONG EMERGENCY CARE STAFF IN HUNGARY: PREVALENCE AND INTERVENTION POSSIBILITIES - A QUASI-EXPERIMENTAL STUDY
Mar 18, 2026, 21:38 PM -
ESTIMATING THE COST-EFFECTIVENESS OF SPARSENTAN RELATIVE TO REAL-WORLD RENIN-ANGIOTENSIN SYSTEMINHIBITION STANDARD OF CARE FOR IMMUNOGLOBULIN A NEPHROPATHY: A PATIENT-LEVEL MICROSIMULATION
Mar 18, 2026, 21:38 PM -
A NOVEL APPROACH- COLLABORATION BETWEEN SPEECH THERAPISTS, CLINICIANS, AND TRANSLATION TEAMS TO GENERATE GLOBAL ASSESSMENTS FOR STROKE PATIENTS
Mar 18, 2026, 21:38 PM -
COMPARING HEALTH OUTCOMES BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) STATUS AND RISK LEVEL: FINDINGS FROM THE US NATIONAL HEALTH AND WELLNESS SURVEY
Mar 18, 2026, 21:38 PM -
MIND THE GAP:EVALUATION OF ARTIFICIAL INTELLIGENCE (AI) ASSISTED EVIDENCE GAP ANALYSIS APPROACHES FOR PCSK-9 INHIBITORS
Mar 18, 2026, 21:38 PM -
TREATMENT DELAYS IN IBD: A MULTI-SITE REAL-WORLD ANALYSIS ACROSS UC HEALTH
Mar 18, 2026, 21:38 PM -
VALIDATION OF A TRANSTHYRETIN AMYLOID CARDIOMYOPATHY (ATTR-CM) UNITED STATES (US) CLAIMS-BASED CODING ALGORITHM
Mar 18, 2026, 21:38 PM -
VALUE-BASED DECISION BOUNDARIES ANALYSIS (VB-DBA): A NOVEL METHOD OF INTEGRATING NETWORK META-ANALYSIS AND COST-EFFECTIVENESS MODELLING TO ESTIMATE PRICING THRESHOLDS BASED ON TARGET PRODUCT PROFILES
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS ANALYSIS OF THRUST CHUNA MANUAL THERAPY COMPARED WITH NON-THRUST CHUNA OR USUAL CARE IN PATIENTS WITH NON-ACUTE LOW BACK PAIN
Mar 18, 2026, 21:38 PM -
ASSESSING THE PSYCHOMETRIC PROPERTIES OF TWO INSTRUMENTS MEASURING ATTITUDES TOWARDS AI AND THEIR ASSOCIATED FACTORS
Mar 18, 2026, 21:38 PM -
STATIN INITIATION TIME AFTER GRAVES' DISEASE DIAGNOSIS AND THE RISK OF GRAVES' ORBITOPATHY: A ONE-YEAR LANDMARK ANALYSIS
Mar 18, 2026, 21:38 PM -
REAL-WORLD SAFETY OF XANOMELINE/TROSPIUM CHLORIDE IN SCHIZOPHRENIA MANAGEMENT
Mar 18, 2026, 21:38 PM
